We are live on ! Find out more
GILD icon

Gilead Sciences

1,626 hedge funds and large institutions have $76.4B invested in Gilead Sciences in 2020 Q2 according to their latest regulatory filings, with 161 funds opening new positions, 632 increasing their positions, 682 reducing their positions, and 161 closing their positions.

New
Increased
Maintained
Reduced
Closed

2% more capital invested

Capital invested by funds: $75B → $76.4B (+$1.42B)

0% more first-time investments, than exits

New positions opened: 161 | Existing positions closed: 161

0% less call options, than puts

Call options by funds: $2.02B | Put options by funds: $2.02B

0.7% less ownership

Funds ownership: 79.98%79.28% (-0.7%)

7% less repeat investments, than reductions

Existing positions increased: 632 | Existing positions reduced: 682

1% less funds holding

Funds holding: 1,6441,626 (-18)

56% less funds holding in top 10

Funds holding in top 10: 8939 (-50)

Holders
1,626
Holders Change
-18
Holders Change %
-1.09%
% of All Funds
33.33%
Holding in Top 10
39
Holding in Top 10 Change
-50
Holding in Top 10 Change %
-56.18%
% of All Funds
0.8%
New
161
Increased
632
Reduced
682
Closed
161
Calls
$2.02B
Puts
$2.02B
Net Calls
-$7.91M
Net Calls Change
-$449M
Name Holding Trade Value Shares
Change
Change in
Stake
NAM
1676
Nexpoint Asset Management
Texas
-$2.3M -30,000 Closed
JCAM
1677
Jericho Capital Asset Management
New York
-$2.17M -29,000 Closed
KHLMVGHM
1678
Kranot Hishtalmut Le Morim Ve Gananot Havera Menahelet
Israel
-$1.85M -28,434 Closed
EAM
1679
Eagle Asset Management
Florida
-$2.02M -27,068 Closed
IWA
1680
IBEX Wealth Advisors
New Jersey
-$2M -26,726 Closed
GL
1681
Gemsstock Ltd
United Kingdom
-$1.88M -25,200 Closed
NFG
1682
Norris Financial Group
South Carolina
-$1.75M -23,379 Closed
ETM
1683
Euclidean Technologies Management
Washington
-$1.67M -22,375 Closed
GFP
1684
Gryphon Financial Partners
Ohio
-$1.67M -22,306 Closed
CI
1685
Cavalier Investments
Georgia
-$1.65M -22,000 Closed
Jennison Associates
1686
Jennison Associates
New York
-$1.61M -21,587 Closed
PM
1687
Parametrica Management
Hong Kong
-$1.55M -20,728 Closed
BB
1688
Bell Bank
North Dakota
-$1.5M -20,040 Closed
NCGI
1689
Next Century Growth Investors
Minnesota
-$1.47M -19,700 Closed
AC
1690
Aristides Capital
Kentucky
-$1.37M -18,300 Closed
AIC
1691
Ameritas Investment Company
Nebraska
-$1.4M -17,902 Closed
FC
1692
FORA Capital
Florida
-$1.33M -17,777 Closed
UAS
1693
United Asset Strategies
New York
-$1.27M -17,037 Closed
Wealth Enhancement Advisory Services
1694
Wealth Enhancement Advisory Services
Minnesota
-$1.32M -16,784 Closed
BAC
1695
Boys Arnold & Co
North Carolina
-$1.18M -15,727 Closed
SCP
1696
Stamos Capital Partners
California
-$1.01M -13,454 Closed
SRAM
1697
Spouting Rock Asset Management
Pennsylvania
-$1M -13,409 Closed
HA
1698
H2O AM
United Kingdom
-$991K -13,253 Closed
BFM
1699
Boothbay Fund Management
New York
-$964K -12,900 Closed
HCM
1700
Hollencrest Capital Management
California
-$942K -12,597 Closed

GILD Hedge Fund Activity: Q2 2020 in Review

1,626 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Gilead Sciences (GILD) for Q2 2020, worth a combined $76.4B — up 1.9% from $75B a quarter earlier.

Fund positioning in GILD was balanced in Q2 2020: 161 funds opened new positions, 161 closed out, 632 added to existing stakes and 682 trimmed.

The largest buyer was Capital Research Global Investors, adding an estimated $2.25B. The largest seller was Franklin Resources, cutting an estimated $499M.

  • 1,626 institutional investors held Gilead Sciences (GILD) as of Q2 2020, down from 1,644 in Q1 2020.
  • Funds reported $76.4B of Gilead Sciences stock for Q2 2020, up 1.9% quarter-over-quarter.
  • 161 funds opened new Gilead Sciences positions in Q2 2020 and 161 closed out, a net change of 0 holders.
  • The largest Gilead Sciences buyer in Q2 2020 was Capital Research Global Investors, an estimated $2.25B added.
  • The largest Gilead Sciences seller in Q2 2020 was Franklin Resources, an estimated $499M sold.

Based on aggregated 13F filings for Q2 2020.